Cargando…

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation

PURPOSE: To compare the effects of intravitreal ranibizumab in monotherapy (group A) and combined with photodynamic therapy (PDT) with verteporfin (group B) in retinal angiomatous proliferation (RAP) treatment. METHODS: This was a multicentric, prospective, randomized clinical study conducted with p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arias, Luis, Gómez-Ulla, Francisco, Ruiz-Moreno, José M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876105/ https://www.ncbi.nlm.nih.gov/pubmed/27274190 http://dx.doi.org/10.2147/OPTH.S106092

Ejemplares similares

One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages
por: Park, Young Gun, et al.
Publicado: (2015)

Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation
por: Nakano, Saya, et al.
Publicado: (2012)

Anti-vascular endothelial growth factor monotherapy or combined with verteporfin photodynamic therapy for retinal angiomatous proliferation: a systematic review with meta-analysis
por: Fallico, Matteo, et al.
Publicado: (2023)

Fundus autofluorescence of retinal angiomatous proliferation
por: Saito, Masaaki, et al.
Publicado: (2020)

Successful Treatment of Retinal Angiomatous Proliferation with Intravitreal Triamcinolone and Ranibizumab Injections in a 67-Year-Old Male
por: Haq, Adnaan, et al.
Publicado: (2014)

Retinal Angiomatous Proliferation in a Patient with Retinitis Pigmentosa
por: Kiraly, Peter, et al.
Publicado: (2023)

Retinal Angiomatous Proliferation and Intravitreal Bevacizumab Injection
por: Kang, Jae Hoon, et al.
Publicado: (2007)

Retinal Angiomatous Proliferation in an Eye with Cuticular Drusen
por: Sato, Atsuko, et al.
Publicado: (2015)

Coexistence of retinal angiomatous proliferation and pachychoroid phenotype
por: Saurabh, Kumar, et al.
Publicado: (2020)

A Case of Chorioretinitis with Retinal Angiomatous Proliferation
por: Chen, Yanru, et al.
Publicado: (2021)

Bilateral Retinal Angiomatous Proliferation in a Variant of Retinitis Pigmentosa
por: Aloe, G., et al.
Publicado: (2019)

Transcriptional and Distributional Profiling of Microglia in Retinal Angiomatous Proliferation
por: Schlecht, Anja, et al.
Publicado: (2022)

Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
por: Fernández, Maribel, et al.
Publicado: (2012)

Bimonthly half-dose ranibizumab in large pigment epithelial detachment and retinal angiomatous proliferation with high risk of retinal pigment epithelium tear: a case report
por: Monés, Jordi, et al.
Publicado: (2013)

Characteristic Findings of Optical Coherence Tomography in Retinal Angiomatous Proliferation
por: Lim, Eun-Hae, et al.
Publicado: (2013)

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration
por: Williams, Patrick D, et al.
Publicado: (2012)

Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy
por: Ma, I-Hsin, et al.
Publicado: (2021)

Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
por: Liang, Xuemei, et al.
Publicado: (2022)

Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation
por: Lee, Jae Hyung, et al.
Publicado: (2017)

Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation
por: Chou, Hung-Da, et al.
Publicado: (2017)

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
por: Takahashi, Kanji, et al.
Publicado: (2018)

Angiographic results of retinal-retinal anastomosis and retinal-choroidal anastomosis after treatments in eyes with retinal angiomatous proliferation
por: Saito, Masaaki, et al.
Publicado: (2012)

Erratum to: short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation
por: Chou, Hung-Da, et al.
Publicado: (2017)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Intravitreal ranibizumab, photodynamic therapy, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma
por: Fong, Angie H. C., et al.
Publicado: (2010)

Retinal Pigment Epithelium Tear after Vitrectomy for Vitreomacular Traction Syndrome in an Eye with Retinal Angiomatous Proliferation
por: Baba, Takayuki, et al.
Publicado: (2013)

Triglyceride-derived fatty acids reduce autophagy in a model of retinal angiomatous proliferation
por: Heckel, Emilie, et al.
Publicado: (2022)

Intraretinal Cysts as a Manifestation of Retinal Angiomatous Proliferation in Optical Coherence Tomography Angiography
por: Kałużny, Jakub J., et al.
Publicado: (2022)

Efficacy of ranibizumab combined with photodynamic therapy on wet age-related macular degeneration
por: Chen, Ling, et al.
Publicado: (2020)

Three-Year Outcomes of Intravitreal Aflibercept Injections for Retinal Angiomatous Proliferation According to Disease Stage
por: Huang, Ya-Yun, et al.
Publicado: (2022)

Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy
por: Nemoto, Rei, et al.
Publicado: (2012)

Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome
por: Kim, Jae Min, et al.
Publicado: (2017)

3-year-data of combined navigated laser photocoagulation (Navilas) and intravitreal ranibizumab compared to ranibizumab monotherapy in DME patients
por: Herold, Tina Rike, et al.
Publicado: (2018)

Photodynamic Therapy in Combination with Doxorubicin Is Superior to Monotherapy for the Treatment of Lung Cancer
por: Cacaccio, Joseph C., et al.
Publicado: (2022)

Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
por: Hikichi, Taiichi, et al.
Publicado: (2016)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
por: Morris, Rodney J, et al.
Publicado: (2011)

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy
por: McAllister, Ian L, et al.
Publicado: (2021)

1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy
por: Wong, Ian Y., et al.
Publicado: (2015)

Retinal angiomatous proliferation associated with risk alleles of ARMS2/HTRA1 gene polymorphisms in Japanese patients
por: Ohkuma, Yasuhiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nno4nrhvnam8domrkp6m431qkq